Company page

Hybio Pharmaceutical Co., Ltd. Class A

Hybio Pharmaceutical Co., Ltd. Class A is a publicly traded company in China, with a market capitalization of approximately 2.76 billion USD. The company focuses on the pharmaceutical industry, providing a range of products and services. As a key player in its market, Hybio is committed to advancing healthcare solutions and improving patient outcomes.

profile300199:SZSEAI content: aiUpdated June 24, 2026/company/hybio-pharmaceutical/c-wwscjd9x
Hybio Pharmaceutical Co., Ltd. Class A logo
Ticker
300199:SZSE
Asset type
Stock
Market cap
$2.76B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
SZSE
Currency
CNY